Effects of Nocturnal Hemodialysis on Melatonin Rhythm and Sleep-Wake Behavior: An Uncontrolled Trial

American Journal of Kidney Diseases

Volumn 53, Issue 4, 2009, Pages 658-664

  Koch, Birgit C P ^a   Hagen, E Christiaan ^a   Nagtegaal, J Elsbeth ^a   Boringa, Jan B S ^a   Kerkhof, Gerard A ^b,c   Ter Wee, Piet M ^d  

^a MEANDER MEDICAL CENTER   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

melatonin; nocturnal hemodialysis; polysomnography; Sleep wake rhythm

Indexed keywords

MELATONIN;

ADULT; AGED; ARTICLE; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; KIDNEY FAILURE; MALE; OXYGEN SATURATION; POLYSOMNOGRAPHY; QUESTIONNAIRE; REM SLEEP; SLEEP; SLEEP WAKING CYCLE; WAKEFULNESS;

ADULT; AGED; AGED, 80 AND OVER; CIRCADIAN RHYTHM; FEMALE; HEALTH SURVEYS; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MELATONIN; MIDDLE AGED; POLYSOMNOGRAPHY; RENAL DIALYSIS; SALVIA; SLEEP; TREATMENT OUTCOME; WAKEFULNESS;

EID: 62749201828     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2008.08.006     Document Type: Article

References (30)

1. Parker K.P. Sleep disturbances in dialysis patients. Sleep Med Rev 7 (2003) 131-143
2. Parker K.P., Bliwise D.L., and Rye D.B. Hemodialysis disrupts basic sleep regulatory mechanisms: Building hypotheses. Nurs Res 49 (2000) 327-332
3. Nagtegaal E., Peeters T., Swart W., Smits M., Kerkhof G., and van der Meer G. Correlation between concentrations of melatonin in saliva and serum in patients with delayed sleep phase syndrome. Ther Drug Monit 20 (1998) 181-183
4. Akerstedt T., Fröberg J.A., Friberg Y., and Wetterberg L. Melatonin excretion, body temperature and subjective arousal during 64 hours of sleep deprivation. Psychoneuroendocrinology 4 (1979) 219-225
5. Tzischinsky O., Shlitner A., and Lavie P. The association between the nocturnal sleep gate and nocturnal onset of urinary 6-sulfametoxymelatonin. J Biol Rhythms 8 (1993) 199-209
6. Karasek M., Szuflet A., Chrzanowski W., Zylinska K., and Swietoslawski J. Decreased melatonin nocturnal concentrations in hemodialyzed patients. Neuro Endocrinol Lett 26 (2005) 653-656
7. Vaziri N.D., Oveisi F., Wierszbiezki M., Shaw V., and Sporty L.D. Serum melatonin and 6-sulfatoxymelatonin in end-stage renal disease: Effect of hemodialysis. Artif Organs 17 (1993) 764-769
8. Gotch F. The current place of urea kinetic modeling with respect to different dialysis modalities. Nephrol Dial Transplant 13 (1998) 10-14
9. Sweere Y., Kerkhof G.A., De Weerd A.W., Kamphuisen H.A., Kemp B., and Schimsheimer R.J. The validity of the Dutch Sleep Disorders Questionnaire (SDQ). J Psychosom Res 45 (1998) 549-555
10. Carskadon M.A., and Rechtschaffen A. Monitoring and staging human sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. (ed 4) (2005), Elsevier-Saunders, Philadelphia, PA 1359-1377
11. Rechtschaffen A., and Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects (1968), US Government Printing Office, National Institutes of Health, Washington DC
12. Renine: Databank Registration Kidney Replacement Therapy in The Netherlands, Data 2005. www.renine.nl Accessed January 10, 2007
13. Hirshkowitz M. Normal human sleep: An overview. Med Clin North Am 88 (2004) 551-565
14. Kushida C.A., Littner M.R., Morgenthaler T., et al. Practice parameters for the indications for polysomnography and related procedures: An update for 2005. Sleep 28 (2005) 499-521
15. Siegel J.M. REM sleep. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. (ed 4) (2005), Elsevier-Saunders, Philadelphia, PA 120-135
16. Pierratos A. Nocturnal home haemodialysis: An update on a 5-year experience. Nephrol Dial Transplant 14 (1999) 2835-2840
17. Walsh M., Culleton B., Tonelli M., and Manns B. A systematic review on the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67 (2005) 1500-1507
18. Hanly P.J., Gabor J.Y., Chan C., and Pierratos A. Daytime sleepiness in patients with CRF: Impact of nocturnal hemodialysis. Am J Kidney Dis 41 (2003) 403-410
19. Hanly P., Chan C., and Pierratos A. The impact of nocturnal hemodialysis on sleep apnea in ESRD patients. Nephrol News Issues 17 (2003) 19-21
20. Hanly P.J., and Pierratos A. Improvement of sleep apnea in patients with chronic renal failure who undergo nocturnal hemodialysis. N Engl J Med 344 (2001) 102-107
21. Czeisler C.A., Buxton O.M., and Singh Khalsa S.B. The human circadian timing system and sleep-wake regulation. In: Kryger M.H., Roth T., and Dement W.C. (Eds). Principles and Practice of Sleep Medicine. (ed 4) (2005), Elsevier-Saunders, Philadelphia, PA 375-394
22. Viljoen M., Steyn M.E., van Rensburg B.W.J., and Reinach S.G. Melatonin in chronic renal failure. Nephron 60 (1992) 138-143
23. Holmes E.W., Hojvat S.A., Kahn S.E., and Bermes Jr. E.W. Testicular dysfunction in experimental chronic renal insufficiency: A deficiency of nocturnal pineal N-acetyltransferase activity. Br J Exp Pathol 70 (1989) 349-356
24. Ferchland A., Rettkowski O., Pönicke K., Deuber H.J., Ostens B., and Brodde O.E. Effects of uremic plasma on alpha- and beta-adrenoceptors subtypes. Nephron 80 (1998) 46-50
25. Geron R., Shurtz-Swirski R., Sela S., et al. Polymorphonuclear leucocyte priming in long intermittent nocturnal haemodialysis-Is melatonin a player?. Nephrol Dial Transplant 21 (2006) 3196-3201
26. Scheer F.A.J.L., Montfrans van G.A., Someren van E.J.W., Mairuhu G., and Buijs R.M. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43 (2004) 192-197
27. Jonas M., Garfinkel D., Zisapel N., Laudon M., and Grossman E. Impaired nocturnal melatonin secretion in non-dipper hypertensive patients. Blood Pressure 12 (2002) 19-24
28. Simko F., and Paulis L. Melatonin as a potential antihypertensive treatment. J Pineal Res 42 (2007) 319-322
29. Lüdemann P., Zwernemann S., and Lerchl A. Clearance of melatonin and 6-sulfatoxymelatonin by hemodialysis in patients with end-stage renal disease. J Pineal Res 3 (2001) 222-227
30. Koch BCP, Nagtegaal JE, Hagen EC, et al: Subjective sleep efficiency of haemodialysis patients. Clin Nephrol (in press)